Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection

Numerous canonical cellular signaling pathways modulate hepatitis B virus (HBV) replication. HBV genome products are known to play a significant role in regulating these cellular pathways for the liver’s viral-related pathology and physiology and have been identified as the main factor in hepatocarc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yan, Qiu, Yuanwang, Davgadorj, Chantsalmaa, Zheng, Chunfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894711/
https://www.ncbi.nlm.nih.gov/pubmed/35252042
http://dx.doi.org/10.3389/fcimb.2022.847539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894711/
https://www.ncbi.nlm.nih.gov/pubmed/35252042
http://dx.doi.org/10.3389/fcimb.2022.847539

Ejemplares similares